Q3 2013

Source filing unavailable

Q3 2013 · —

Revenue

$156.47M

+20.6% vs Q3 2012

Net Income

$37.89M

+27.9% vs Q3 2012

EPS Diluted

$0.46

+35.3% vs Q3 2012

Operating Income$57,918,000+25.6%

Operating Cash Flowderived$37,396,000−8.2%

Same quarter

Metric	Q3 2013	Q3 2012	Q3 2011	Q3 2010
Revenue	$156.47M	$129.78M	$102.37M	$90.83M
Net Income	$37.89M	$29.62M	$27.94M	$33.25M
EPS Diluted	$0.46	$0.34	$0.31	$0.33

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR